Avalo Therapeutics, Inc. · NASDAQ:AVTX

Affinity Asset Advisors, LLC reported a 5.50% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 14, 2026

Affinity Asset Advisors, LLC reported a 5.50% stake in Avalo Therapeutics, Inc., 1,340,840 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G/A).

Stake
5.50%
Shares
1,340,840
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Asset Advisors, LLC5.50%1,340,840
Michael Cho5.50%1,340,840

Source

View original at SEC

Related